|
Generic:
|
| Mirogabalin |
| |
|
Therapeutic Class:
|
|
Gabapentinoid Products
|
| |
|
Composition:
|
| Each Miroca tablet contains Mirogabalin Besilate equivalent to 5, 10, or 15 mg of Mirogabalin. |
| |
|
Description:
|
|
Miroca (Mirogabalin) is an orally administered Gabapentinoid. Mirogabalin is considered to exhibit its analgesic effect by reducing calcium current via binding to the α2δ subunit, which plays an auxiliary role in the function of voltage-gated calcium channels in the nervous system. The analgesic effect of Mirogabalin is also suggested to involve activation of the noradrenergic pathway.
|
| |
|
Indications:
|
| Miroca is used for the treatment of peripheral neuropathic pain in adults. |
|
|
Dosage:
|
| For adults, administer an initial oral dose of 5 mg twice daily before meals, and then increase the dose by 5 mg per dose with an interval of at least 1 week up to 15 mg twice daily. The dose may be increased or decreased appropriately in the range between 10 mg and 15 mg twice daily, based on individual patient age or symptoms. |
|
|
Presentations:
|
| Miroca Tabs (5 mg, 10 mg, 15 mg) are available in a pack size of 14’s |
|
|
|
|
